Parental Psychological Response to Prenatal Congenital Heart Defect Diagnosis

Cristina Tecar1,2, Lacramioara Eliza Chiperi3, Dafin Fior Muresanu1,2

  • 1RoNeuro Institute for Neurological Research and Diagnostic, 400364 Cluj-Napoca, Romania.

PubMed

Insights

Parents of children with prenatal congenital heart defects (CHDs) experience significant psychological distress, including anxiety and depression. Early screening and multidisciplinary support are crucial for improving parental well-being.

Area of Science:

  • Psychology
  • Perinatology
  • Pediatric Cardiology

Background:

  • Prenatal diagnosis of congenital heart defects (CHDs) presents unique psychological challenges for parents.
  • Existing literature highlights the need for a comprehensive understanding of parental psychological responses to prenatal CHD diagnoses.

Purpose of the Study:

  • To systematically review and synthesize recent literature on the psychological impact on parents of children diagnosed with CHDs prenatally.
  • To identify common psychological outcomes, coping mechanisms, and predictors of distress in this population.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases (PubMed, Science direct, Embase, Scopus, Medline, Clarivate) up to February 2025.
  • Search terms included "congenital heart defect," "CHD," "prenatal diagnosis," "psychological impact," "parental distress," and "coping."
  • Included studies encompassed qualitative and quantitative designs, analyzing data from 673 parents across four continents.

Main Results:

  • Eighteen studies revealed high rates of parental anxiety (up to 65%) and depression (up to 45.7%) following prenatal CHD diagnosis.
  • Common psychological outcomes included stress, post-traumatic stress, varied coping strategies (adaptive and maladaptive), and altered maternal-fetal attachment.
  • Predictors of distress involved diagnosis timing, parental demographics, social support, and defect severity; recommended interventions focused on screening, communication, counseling, and support.

Conclusions:

  • Parents facing prenatal CHD diagnoses are at elevated risk for psychological distress.
  • A multidisciplinary approach is essential for providing comprehensive information and support regarding diagnosis, interventions, and outcomes.
  • Integrated psychosocial care is vital for enhancing the quality of care for these families.
Abstract

Related Concept Videos

Psychological Responses to Stress01:20

Psychological Responses to Stress

Psychological responses to stress encompass the various cognitive and emotional reactions individuals experience when faced with challenging or threatening situations, such as a job loss. Prolonged exposure to stressors can disturb emotional balance, increasing negative emotions (e.g., anxiety and sadness) and diminishing positive emotions (e.g., joy and satisfaction). These persistent emotional shifts are associated with an increased risk of both physical illness and mental health issues, such...
98
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
716
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K